Prevalence and Risk Factors of Diabetic Macular Edema in Diabetic Retinopathy Patient in Chumphon Khet Udomsakdi Hospital
Keywords:
Diabetic macular edema, Diabetic retinopathyAbstract
Background : The main cause to decrease vision in diabetic retinopathy patients is diabetic macular edema. Recently, This disease tend to be increase in people while it had limited knowledge about factors of diabetic macular edema in Thailand.
Objectives : To investigate prevalence and risk factors that effect to diabetic macular edema in diabetic retinopathy patients in Chumphon Khet Udomsak Hospital, Thailand.
Method : A retrospective cohort study was conducted by a review medical record of diabetic retinopathy patients in Chumphon Khet Udomsak Hospital from 1 January 2021 to 30 September 2021. The analysis of prevalence and risk factors relate to diabetic macular edema from diabetic retinopathy were performed by multivariate logistic regression analysis
Results : 15 diabetic retinopathy patients from 273 patients (5.49%) and 2 risk factors that relate to diabetic macular edema including hyperlipidemia (Adj OR = 10.28, 95% CI = 1.31 – 80.33, p = 0.026) and fasting blood glucose is greater than or equal to 200 mg/dL (Adj OR = 4.32, 95% CI = 1.45 – 12.85, p = 0.008).
Conclusion : Prevalence of diabetic macular edema in Chumphon Khet Udomsak Hospital, Thailand was 5.49%. From this patients, there were 2 risk factors that relate to diabetic macular edema including hyperlipidemia and fasting blood glucose is greater than or equal to 200 mg/dL.
References
สถาบันวิจัยและประเมินเทคโนโลยีทางการแพทย์ กรมการแพทย์ กระทรวงสาธารณสุข.เอกสารข้อมูล: สถานการณ์โรคเบาหวาน/ความดันโลหิตสูงและภาวะแทรกซ้อนในประเทศไทย. กรุงเทพมหานคร; 2556.
Rawdaree P, Ngarmukos C, Deerochanawong C, Suwanwalaikorn S, Chetthakul T, Krittiyawong S, et al. Thailand diabetes registry (TDR) project: clinical status and long term vascular complications in diabetic patients. 2006;89(Suppl 1):S1-9.
Cugati S, Kifley A, Mitchell P, Wang JJ. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res Clin Pract. 2006;74:301–8.
Pedro RA, Ramon SA, Marc BB, Juan FB, Isabel MM. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the north-east of Spain, a population-based study. Ophthalmic Epidemiol. 2010;17:251–65.
Bertelsen G, Peto T, Lindekleiv H, Schirmer H, Solbu MD, Toft I, et al. Tromsø eye study: prevalence and risk factors of diabetic retinopathy. Acta Ophthalmol. 2013;91:716–21.
Knudsen LL, Lervang HH, Lundbye-Christensen S, Gorst-Rasmussen A. The North Jutland County Diabetic Retinopathy Study: population characteristics. Br J Ophthalmol. 2006;90:1404–9.
Roy MS, Klein R, O’Colmain BJ, Klein BE, Moss SE, Kempen JH. The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol. 2004;122:546–51.
Kempen JH, O’Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al. Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122:552–63.
Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 2010;304:649–56.
Thapa R, Joshi DM, Rizyal A, Maharjan N, Joshi RD. Prevalence, risk factors and awareness of diabetic retinopathy among admitted diabetic patients at a tertiary level hospital in Kathmandu. Nepal J Ophthalmol 2014;6:24–30.
Kahloun R, Jelliti B, Zaouali S, Attia S, Ben Yahia S, Resnikoff S, et al. Prevalence and causes of visual impairment in diabetic patients in Tunisia, North Africa. Eye. 2014;28:986–91.
Jee D, Lee WK, Kang S. Prevalence and risk factors for diabetic retinopathy: the Korea National Health and nutrition examination survey 2008–2011. Invest Ophthalmol Vis Sci. 2013;54:6827–33.
Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology. 2009;116:311–8.
Zheng Y, Lamoureux EL, Lavanya R, Wu R, Ikram MK, Wang JJ, et al. Prevalence and risk factors of diabetic retinopathy in migrant Indians in an urbanized society in Asia: the Singapore Indian eye study. Ophthalmology. 2012;119:2119–24.
Al Ghamdi AH, Rabiu M, Hajar S, Yorston D, Kuper H, Polack S. Rapid assessment of avoidable blindness and diabetic retinopathy in Taif, Saudi Arabia. Br J Ophthalmol. 2012;96:1168–72.
Dehghan MH, Katibeh M, Ahmadieh H, Nourinia R, Yaseri M. Prevalence and risk factors for diabetic retinopathy in the 40 to 80 year-old population in Yazd, Iran: the Yazd eye study. J Diabetes. 2015;7:139–41.
Mathenge W, Bastawrous A, Peto T, Leung I, Yorston D, Foster A, et al. Prevalence and correlates of diabetic retinopathy in a population-based survey of older people in Nakuru, Kenya. Ophthalmic Epidemiol. 2014;21:169–77.
Sharew G, Ilako DR, Kimani K, Gelaw Y. Prevalence of diabetic retinopathy in Jimma University Hospital, Southwest Ethiopia. Ethiop Med J. 2013;51:105–13.
Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay eye study. Ophthalmology. 2008;115:1869–75.
Al-Rubeaan K, Abu El-Asrar AM, Youssef AM, Subhani SN, Ahmad NA, Al-Sharqawi AH, et al. Ibrahim HM. Diabetic retinopathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. Acta Ophthalmol. 2015;93:e140–7.
Pugliese G, Solini A, Zoppini G, Fondelli C, Zerbini G, Vedovato M, et al. Renal Insufficiency and Cardiovascular Events (RIACE) Study Group. High prevalence of advanced retinopathy in patients with type 2 diabetes from the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Diabetes Res Clin Pract. 2012;98:329–37.
Dutra Medeiros M, Mesquita E, Papoila AL, Genro V, Raposo JF. First diabetic retinopathy prevalence study in Portugal: RETINODIAB study-evaluation of the screening programme for Lisbon and Tagus Valley region. Br J Ophthalmol. 2015;99:1328–33.
Nathoo N, Ng M, Rudnisky CJ, Tennant MT. The prevalence of diabetic retinopathy as identified by teleophthalmology in rural Alberta. Can J Ophthalmol. 2010;45:28–32.
Esteves JF, Kramer CK, Azevedo MJ, Stolz AP, Roggia MF, Larangeira A, et al. Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Rev Assoc Med Bras. 2009;55:268–73.
Villena JE, Yoshiyama CA, Sanchez JE, Hilario NL, Merin LM. Prevalence of diabetic retinopathy in Peruvian patients with type 2 diabetes: results of a hospital-based retinal telescreening program. Rev Panam Salud Publica. 2011;30:408–14.
Thomas RL, Distiller L, Luzio SD, Chowdhury SR, Melville VJ, Kramer B, et al. Ethnic differences in the prevalence of diabetic retinopathy in persons with diabetes when first presenting at a diabetes clinic in South Africa. Diabetes Care. 2013;36:336–41.
Kaidonis G, Mills RA, Landers J, Lake SR, Burdon KP, Craig JE. Review of the prevalence of diabetic retinopathy in indigenous Australians. Clin Exp Ophthalmol. 2014;42:875–82.
Supapluksakul S, Ruamviboonsuk P, Chaowakul W. The prevalence of diabetic retinopathy in Trang province determined by retinal photography and comprehensive eye examination. J Med Assoc Thai. 2008;91:716-21.
Koozekanani D, Roberts C, Katz SE, Herderick EE. Intersession repeatability of macular thickness measurements with the Humphrey 2000 OCT. Invest Ophthalmol Vis Sci. 2000;41:1486–91.
Hee MR, Puliafito CA, Wong C, Duker, JS, Reichel E, Rutledge B, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113:1019–29.
Hee MR, Puliafito CA, Duker JS, Reichel E, Coker JG, Wilkins JR, et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 1998;105:360–70.
Cochran WG. Sampling techniques. Oxford: John Wiley; 1953.
Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35: 556-64.
Diep TM, Tsui I. Risk factors associated with diabetic macular edema.Diabetes Res Clin Pract 2013;100:298-305.
Das R, Kerr R, Chakravarthy U, Hogg RE. Dyslipidemia and diabetic macular edema: a systematic review and meta-analysis. Ophthalmology. 2015;122:1820-7.
Acan D, Calan M, Er D, Arkan T, Kocak N, Bayraktar F, et al. The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey.BMC Ophthalmol. 2018;18:1-8.
Torimoto K, Okada Y, Mori H, Tanaka YJ. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol 2013;12:1-7.
Tan GS, Cheung N, Simo R, Cheung GC, Wong TY. endocrinology. Diabetic macular oedema. Lancet Diabetes Endocrinol 2017;5:143-55.
Sasaki A, Horiuchi N, Hasewgawa K, Uehara M. Development of diabetic retinopathy and its associated risk factors in type 2 diabetic patients in Osaka district, Japan: a long-term prospective study. Diabetes Res Clin Pract 1990;10:257-63.
Chou T, Wu P, Kuo JZ, Lai C, Kuo CJ. Relationship of diabetic macular oedema with glycosylated haemoglobin. Eye 2009;23(6):1360-3.
Varma R, Bressler NM, Doan QV, Gleeson M, Danese M, Bower JK, et al. Prevalence of and risk factors for diabetic macular edema in the United States.JAMA Ophthalmol. 2014;132:1334-40.
Edwin H, Han DP, Ramsay RC, Cantrill HL, Bennett SR, Dev S, et al. Diabetic macular edema associated with glitazone use. Retina. 2006;26:562-70.
Downloads
Published
Versions
- 2026-01-30 (6)
- 2024-05-18 (5)
- 2024-05-18 (4)
- 2024-05-01 (3)
- 2024-05-01 (2)
- 2024-05-01 (1)
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพิ์เป็นลิขสิทธิ์ของวารสารโรงพยาบาลชลบุรี